The connection between occupational exposure to volatile organic compounds (VOCs) and the resulting internal doses is complicated by variability in air levels from day to day and by nonlinear kinetics of metabolism. We investigated long-term liver doses of VOCs and their metabolites using a physiologically based toxicokinetic model, to which 10,000 random 8-h exposures were inputted. Three carcinogenic VOCs were studied (i.e., benzene, perchloroethylene, and acrylonitrile); these compounds are all bioactivated in the liver and represent a wide range of an important toxicokinetic parameter
The connection between occupational exposure to volatile organic compounds (VOCs) and the resulting internal doses is complicated by variability in air levels from day to day and by nonlinear kinetics of metabolism. We investigated long-term liver doses of VOCs and their metabolites using a physiologically based toxicokinetic model, to which 10,000 random 8-h exposures were inputted. Three carcinogenic VOCs were studied (i.e., benzene, perchloroethylene, and acrylonitrile); these compounds are all bioactivated in the liver and represent a wide range of an important toxicokinetic parameter
For each VOC, simulations were performed using mean air concentrations (m X ) between 0.0003 and 1 mg/l (which covers both linear and saturated metabolism) and using coefficients of variation of exposure (CV X ) between 0.23 and 2.18 (which includes most occupational settings). Two long-term measures of internal dose were examined, i.e., the area under the liver concentrationtime curve (AUCL) and the area under the metabolic rate-time curve (AURC). Interestingly, both AUCL and AURC were linear functions of cumulative exposure (CE, mgÁh/l air) even when metabolism was saturated and CV X was large. Yet, at a given CE, both AUCL and AURC were affected by CV X , with the magnitude of the effect increasing with V max Q L ÁK M (i.e., perchloroethylene 5 benzene 5 acrylonitrile). Nonetheless, the effects of CV X were typically only a few percent and should be of little consequence unless a VOC has large values of V max Q L ÁK M , m X , and CV X . We conclude that CE should be a sufficient predictor of the dose of either the parent chemical (VOC) or its metabolite in the liver, even when metabolism is nonlinear. We also observed that AUCL and AURC were sensitive to changes in values of model parameters in the high-variability scenarios, suggesting that (when CV X is large) the population variability of AUCL and AURC can be quite large at a fixed CE.
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Persons are exposed to toxic substances in the air of their communities, their homes, and their workplaces. Among these locations, levels tend to be greatest in the workplace where chemicals are produced or used in concentrated form.
If exposures are of sufficient intensity and duration, critical tissues are damaged and workers suffer adverse health effects. Here, we are interested in the relationship between airborne exposure and the dose of a contaminant accumulated by a worker over many years. Thus, we only consider chronic effects of exposure and not acute, allergenic, or reproductive effects, where the timing as well as the magnitude of exposures can be important.
As a worker breathes a contaminant at a given air level (mg/l), he or she takes up some portion of the chemical in the lungs. The uptake is related to the breathing rate (l/h) and the retention, a dimensionless quantity that depends upon the physical and chemical properties of the contaminant (gaseous or particulate, solubility, particle size, etc.). Thus, during a brief period of time, uptake 5 (air level ) 3 (breathing rate) 3 retention, with units of mg/h. Once the contaminant is cleared from the lungs, it can be distributed to tissues and eliminated by a host of excretory and metabolic processes. The difference between input and output gives rise to an internal mass, or burden (mg), of the substance at a particular time. From mass-balance considerations, the rate at which the burden changes during a brief period is dðburdenÞ=dt ¼ uptake À ðelimination rateÞ 3 burden where the elimination rate has units of h À1 . By integrating the burden over time, the internal dose can be derived, where dose ¼ R t 0 burdenðtÞ dt, with units of mgÁh. The internal dose can be defined more conventionally as the area under the tissue concentration-time curve, i.e., AUC ¼ R t 0 burdenðtÞ volume dt, with units of mgÁh/l. Since the internal dose ultimately determines the extent of tissue damage, our ability to relate workers' exposures to the corresponding AUC values is fundamental to understanding and preventing occupational diseases.
The connection between exposure and AUC is complicated by the intermittent nature of the occupational regimen, where workers tend to be exposed for 8 h per day, and by the profound variability in air levels occurring from one workday to another. Occupational exposures typically vary 15-fold from day to day within workers (median value), and variation greater than 70-fold is observed in about a fourth of occupational groups (Kromhout et al., 1993) . Given such great variability, it is reasonable to ponder whether day-to-day fluctuations in air levels might alter the relationship between exposure and internal dose. If air levels vary greatly from day to day (about some mean value), would the AUC differ from that observed when the air level is the same (mean) value each day? This subject has received only limited attention (Kumagai and Matsunaga, 1995; Rappaport, 1985 Rappaport, , 1991 Roach, 1966 Roach, , 1977 Smith, 1987; Smith, 1992) .
Logically, exposure variability can affect the relationship between exposure and internal dose only if two conditions are met (Rappaport, 1991) . First, the contaminant must be eliminated from the body sufficiently rapidly so as not to accumulate from week to week. This is because substances that accumulate (notably insoluble dusts, heavy metals, and lipophilic organic compounds) achieve burdens much greater than the mass taken up in a single day and thereby are reasonably invariant to daily fluctuations in air levels. For such contaminants, cumulative exposure (CE), i.e., the product of the mean exposure and time (with units of mgÁh/l), should be a valid predictor of the long-term internal dose (AUC). Second, the contaminant must be either taken up by, or eliminated from, the body by a nonlinear process over the relevant range of exposure. This condition is necessary because linear kinetics would maintain a strict proportionality between AUC and CE even when the contaminant is rapidly absorbed and eliminated (a restatement of 'Haber's Law') (Cox, 1995; Olson and Cumming, 1981; Rappaport, 1991) .
Volatile organic compounds (VOCs) are rapidly eliminated via nonlinear (saturable) metabolism. Since many VOCs have been associated with chronic health effects, the purpose of this investigation is to explore the influence of exposure variability upon the internal doses of these compounds and their metabolites. Points will be illustrated with three chemicals that are knownorsuspectedhumancarcinogens,namely,benzene (Hayes et al., 1997; Andrews, 1996, 1997; Snyder, 2002) , perchloroethylene (Lash and Parker, 2001) , and acrylonitrile (Collins and Strother, 1999; Kirman et al., 2000) . These substances were chosen because they are biotransformed in the liver by phase-I metabolism and possess an important toxicokinetic parameter (
, to be defined) that ranges in value from low (perchloroethylene), to moderate (benzene), to high (acrylonitrile). The carcinogenicity of all three compounds is likely due to the action of one or more reactive metabolites. The sites of tumor formation include the hematopoietic system (benzene), liver and kidney (perchloroethylene), and the brain (acrylonitrile) .
In what follows, we will couple a random time series of simulated air levels, representing the variability in occupational exposure over many years, with a physiologically based toxicokinetic model, representing the disposition of VOCs and metabolite production in the body. Such toxicokinetic models provide the means to relate external exposure to internal levels and, thus, are well suited for evaluating the doses of VOCs and their metabolites following prolonged periods of occupational exposure.
MATERIALS AND METHODS
Toxicokinetic model. Figure 1 displays a physiologically based toxicokinetic model that is widely accepted as a reasonable depiction of mammalian absorption and elimination of VOCs (Andersen, 1981a; Droz and Guillemin, 1983; Ramsey and Andersen, 1984) . The input to the model is the contaminant, at air concentration X (mg/l), inhaled into a central (lungs/blood) compartment at the alveolar ventilation rate Q Alv (l/h). The contaminant is absorbed into the arterial blood according to its blood-air partition coefficient (l B ). Once inside the body, the chemical is transported at the rate of the cardiac output Q Car (l/h) via the arterial blood at concentration C Art (mg/l). The chemical is distributed to parallel tissue groups, consisting of the liver (L, the only metabolizing tissue), the rapidly perfused tissues (RPT, mainly the central organs), the slowly perfused tissues (SPT, mainly muscles and skin), and the fat (F ), at rates defined by the perfusion rates (Q L for the liver, etc., l/h). The tissue groups are all assumed to be homogenous well-mixed volumes. Transfer of the chemical from the arterial blood to each tissue group is governed by the tissue-blood partition coefficient (l L , etc.) and volume (V L , etc., l); the concentration is designated as C L (mg/l) for the liver, etc. The chemical is cleared from the body either passively, by exhalation at rate
CArtQAlv lB
(mg/h), or by metabolism in the liver to metabolite M at rate R M (mg/h). For benzene, perchloroethylene, and acrylonitrile, note that M would represent the initial epoxide produced by cytochrome P450 metabolism, namely, benzene oxide, perchloroethylene epoxide, and cyanoethylene oxide, respectively.
The nonlinear behavior of the model shown in Figure 1 relates to liver metabolism, which obeys Michaelis-Menten kinetics at rate R M ¼
VmaxðCL=lLÞ KMþðCL=lLÞ
, where V max represents the maximum rate of metabolism (mg/h) and K M (mg/l) is the Þ, the rate of metabolism lies between these limiting values. We also identify the dimensionless quantity Vmax QLÁKM , representing ''the maximum concentration gradient that exists across the liver at a given blood flow'' divided by K M (Andersen, 1981b) . When Vmax QLÁKM ( 1, metabolism is not complete at low substrate concentrations, and the transition from first-to zeroorder behavior is gradual. Conversely, when Vmax QLÁKM ) 1, metabolism is essentially complete at low substrate concentrations, and this transition between kinetic states is abrupt (Andersen, 1981b) .
Model parameters and simulation. The flow rates (l/h) and tissue volumes (l) were scaled to a 70-kg human working at 50 W of exercise according to Tardif et al. (2002) Table 1 , were compiled from (Dobrev et al., 2001; Sweeney et al., 2003; Travis et al., 1990) after scaling V max for a 70-kg human as V max 5V maxc Á 70 0.75 , where V maxc is the scaling coefficient given by the authors.
Simulation involved introducing a time series of 8-h occupational exposures {X i } into the model shown in Figure 1 , where X i (mg/l) is the air concentration during the i th 8-h workday (i 5 1, . . . , 10,000). We modeled X i as a lognormal variate with true (unobservable) mean m X and variance s 2 X (Rappaport, 1991) ; by randomly sampling from a given distribution (defined by m X and s Kromhout et al. (1993) . Note that, for the lognormal variate Ramsey and Andersen (1984) (see Supplementary Data). These equations were solved numerically by Euler's method, using a program written with SAS software (SAS Institute, Cary, NC) and employing a time step Dt of either 0.01 h (benzene and perchloroethylene) or 0.002 h (acrylonitrile), as required to maintain continuity. Following 8 h of simulated exposure at air concentration X i , the inhaled air concentration was reduced to zero, and liver concentrations were monitored until t 5 336 h to ensure complete clearance of the chemical from all tissues. The time series {X i } produced the corresponding time series of internal doses, represented by the AUC of the parent chemical in the liver after each exposure {AUCL i } (mgÁh/l), where AUCL i ¼ P 336=Dt j¼1 C Lij Dt and C Lij is the liver concentration (mg/l), after the j th time step for the i th exposure. Metabolism was monitored in terms of the time series of the amount of metabolite produced from the i th exposure, referred to as the area under the metabolic rate-time curve (Andersen, 1981b) , i.e., AURC i ¼ P 336=Dt j¼1 R Mij Dt (mg), and R Mij is the rate of metabolism (mg/h) after the j th time step for the i th exposure. The long-term liver dose of parent chemical after 10,000 exposures was calculated as AUCL ¼ P 10;000 i¼1 AUCL i (mgÁh/l), and the corresponding long-term dose of metabolite as AURC ¼ P 10;000 i¼1 AURC i (mg). Even though both AUCL and AURC are long-term dose metrics, note that they are dimensionally different.
We focused our models upon the liver and metabolite doses (AUCL and AURC) even though the liver is not necessarily the target of toxicity for the VOCs investigated. Because our model only permits metabolism to take place in the liver, the liver is more sensitive to perturbations in levels of the parent compound than are the blood and other tissue groups. Thus, effects of exposure variability upon AUCL are at least as great as upon the analogous AUC values for other tissues. Likewise, AURC represents a global measure of metabolite production that should be relevant to all tissues where metabolites are ultimately distributed from the liver by the systemic circulation.
Sensitivity analysis. Additional simulations were conducted to determine the sensitivity of the two dose metrics AUCL and AURC to each of the parameters in the model. Each parameter was increased by 1% and the full simulation was repeated for 4 exposure distributions, representing a wide range of mean values (m X 5 0.0003 and 0.3 mg/l) and variability (CV X 5 0.23 and 2.18). While testing sensitivity to blood flow rates, mass balance was maintained by reducing Q SPT , as necessary, to compensate for the 1% increase in Q RPT , Q L , or Q F . Normalized sensitivity coefficients were estimated as the percentage change observed in AUCL or AURC divided by the 1% change in the parameter of interest (e.g., a 2% increase in AUCL or AURC would correspond to a normalized sensitivity coefficient of 2).
RESULTS

Exposure-Dose Relationships for Benzene
To illustrate the effect of exposure variability on the daily liver doses of benzene and its metabolite at a given mean exposure, valuesof{AUCL i }and{AURC i }areplottedversusexposure{X i } in Figure 2 when the mean exposure m X 5 0.010 mg/l (3.13 ppm) and CV X 5 0.23 (very low variability) or CV X 5 2.18 (very high variability). The effect of saturable metabolism is apparent when CV X 5 2.18, but not when CV X 5 0.23; this is due to the much greater range of benzene air levels in the high-variability scenario, relative to the mean value of 0.010 mg/l. Note that the shapes of the nonlinear relationships in Figures 2A and 2B differ when CV X 5 2.18. As benzene metabolism approaches saturation, the ratio of the arterial blood concentration to the exposure concentration (
) increases, and a larger fraction of benzene is Note. l B is the blood-air partition coefficient and l g is the tissue-blood partition coefficient for the g th tissue group [for g 5 rapidly perfused tissues (RPT), slowly perfused tissues (SPT), fat (F), and liver (L)], V max is the maximum rate of metabolism scaled to a 70-kg human, and K M is the Michaelis-Menten constant.
a From Travis et al. (1990) . 
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RAPPAPORT, KUPPER, AND LIN distributed to the fat, where it is stored pending eventual release to the systemic circulation (and the liver) during the subsequent period of zero exposure. This ultimately leads to values of AUCL i that are disproportionably greater than those observed at lower exposure levels. Thus, the relationship between AUCL i and exposure concentration exhibits concave-upwards behavior that becomes pronounced when X i ! 0.05 mg/l ( Fig. 2A) . At the same time, saturation of benzene metabolism leads to reduced uptake and increased passive clearance of benzene. These effects combine to disproportionably reduce metabolism during periods of high benzene exposure and give rise to the concavedownwards shape of the relationship between AURC i and exposure (Fig. 2B) . Accordingly, the rate of metabolite production is substantially saturated, given 8 h of exposure to benzene in the range of 0.2-0.4 mg/l (63-126 ppm). The relationships shown in Figure 2 suggest that large variability in exposure can increase the liver dose of benzene and reduce the corresponding dose of the benzene metabolite at a given mean exposure m X . This is illustrated in Figure 3 ). Yet, the two values of AUCL and AURC only differ by 10-13%, despite the enormous differences in the variability of the two time series {AUCL i } and {AURC i } giving rise to the long-term doses.
The relationships shown in Figure 3 indicate that AUCL and AURC increase linearly with workday when m X 5 0.010 mg/l, regardless of the magnitude of CV X ; that is, the slope for AUCL versus workday [in (mgÁh/l)/d] 5 39m X when CV X 5 0.23, and equals 44 m X when CV X 5 2.18, while the slope for AURC versus workday (in mg/d) 5 2050m X when CV X 5 0.23 and equals 1850 m X when CV X 5 2.18. In fact, the same results were observed for both AUCL and AURC over an extremely wide range of benzene exposures representing kinetics that changed from linear (m X 5 0.0003 mg/l, 0.1 ppm) to fully saturated (m X 5 1.0 mg/l, 313 ppm) (results not shown). Since CE is a linear function   FIG. 2 . Relationships between series of 8-h benzene exposures {X i } and the corresponding series of daily benzene liver doses {AUCL i } (A) and of daily benzene metabolite doses {AURC i } (B) for 10,000 simulated workdays. In each case, the mean benzene exposure m X 5 0.010 mg/l, while the coefficient of variation (CV X ) was either 0.23 or 2.18.
EXPOSURE VARIABILITY AND DOSES OF VOLATILE ORGANIC COMPOUNDS 227 of time, i.e., CE 5 m X 3 t for t representing exposure time in h (t 5 80,000 h in our simulations), then CE must be a good predictor of the long-term internal dose of benzene (AUCL) or its metabolite (AURC), regardless of the variability in air levels from day to day (CV X ). Figure 4 shows graphs of AUCL and AURC versus CE for benzene exposures when m X 5 0.001 or 1.0 mg/l and CV X 5 0.23 or 2.18. Clearly, linear relationships are observed in both cases with intercepts equal to zero and slopes of either AUCL /CE (Figs. 4A and 4B) or AURC/CE (Figs. 4C  and 4D ). (Since CE 5 m X Á t and since AUCL 5 k Á m X Á t, then AUCL is a constant multiple of CE and k 5 AUCL /CE. The same argument holds for AURC). Furthermore, after 10,000 simulated workdays, AUCL and AURC are very close in value for both the low-and high-variability scenarios, indicating that exposure variability had small effects upon AUCL /CE and AURC/CE for benzene when 0.001 m X 1 mg/l.
Effects of Exposure Variability upon AUCL/CE and AURC/CE
It was illustrated in Figures 4A and 4C that, when the toxicokinetics for benzene were linear (m X 5 0.001 mg/l), AUCL /CE and AURC/CE were virtually unchanged for scenarios involving either very low variability (CV X 5 0.23) or very high variability (CV X 5 2.18). However, when benzene metabolism was saturated (m X 5 1.0 mg/l), the slopes differed marginally between scenarios; that is, AUCL /CE increased from 9.45 when CV X 5 0.23 to 9.75 when CV X 5 2.18 (Fig. 4B) , while AURC/CE concurrently decreased from 64.6 to 52.5 l/h (Fig. 4D) . The same behavior was observed for simulations involving perchloroethylene and acrylonitrile, although the magnitudes and patterns of the deviations differed (results not shown). This indicates that, at a given CE, highly variable exposure distributions can lead to marginally different internal doses (AUCL and AURC) than those of low variability.
The effects of exposure variability on the slopes AUCL /CE and AURC/CE (after 10,000 8-h workdays) are summarized in Figures 5A-5F for benzene, perchloroethylene, and acrylonitrile when 0.0003 m X 1.0 mg/l and when CV X 5 0.23, 0.62, and 2.18. For each chemical, AUCL /CE and AURC/CE are hardly affected by exposure variability when m X 0.01 mg/l, even when CV X 5 2.18. However, as m x increases above 0.01 mg/l, upwards divergence of AUCL /CE was observed (Figs. 5A, 5C , and 5E) along with downwards divergence of AURC/CE (Figs. 5B, 5D , and 5F), consistent with increasing saturation The curves represented by CV X 5 0.23 and 0.62 in Figure 5 are very similar, suggesting that low or moderate variation in occupational exposure has little impact upon the relationship between either AUCL /CE and m X or AURC/CE and m X . However, deviations of the high-variability curves (CV X 5 2.18) from the lowvariability curves (CV X 5 0.23) can be large, depending on the particular VOC and on whether AUCL or AURC is being considered. Here we define the high-variability deviation for AUCL/ CE as . These high-variability deviations (in percent) are shown in Figure 6A and Figure 6B for AUCL /CE and AURC/CE, respectively, for the three VOCs in our study. Referring first to AUCL /CE, the maximum deviations differed among the VOCs, i.e., 2% for perchloroethylene, 21% for benzene, and 570% for acrylonitrile (Fig. 6A) . On the other hand, maximum deviations of the AURC/CE were very uniform across the VOCs, ranging between À29 and À31%. Note that these maximum deviations occurred at values of m X between 0.1 and 0.3 mg/l, depending upon the particular VOC. Since the mean exposures corresponding to maximum deviations were on the cusps between linear and saturable metabolism, the low-variability scenario resulted in essentially linear metabolism on all workdays; here, AUCL /CE and AURC/CE were near the baseline values observed at much lower mean exposures (see Fig. 5 ). On the other hand, the high-variability scenario included many days where metabolism was in the saturable range, thereby producing major deviations in AUCL /CE and AURC/CE from their near-baseline values. For example, from Figure 6A , the maximum deviation in AUCL /CE for acrylonitrile occurred when m X 5 0.1 mg/l. Referring to Figure 5E , we see that, when m X 5 0.1 mg/l and CV X 5 0.23, AUCL /CE 5 5.4, a value only marginally greater than the baseline value of 3.8 observed when m X 0.003 mg/l. Yet, when m X 5 0.1 mg/l and CV X 5 2.18, AUCL /CE 5 36.5, a 7-fold deviation from the low-variability scenario! As m X increased above 0.1 mg/l for acrylonitrile, metabolism shifted into the saturable range, and AUCL /CE increased dramatically with m X when CV X 5 0.23; this narrowed the gap in AUCL /CE between the low-and high-variability scenarios.
Effects of
on AUCL/CE and AURC/CE The deviations in AUCL /CE and AURC/CE between highvariability and low-variability scenarios increased in the following order: perchloroethylene 5 benzene 5 acrylonitrile, which matches the order of the toxicokinetic parameter
) 1, the transition from first-to zero-order kinetics is abrupt, being described as 'flip-flop' behavior (Andersen, 1981b) . As a consequence, the toxicokinetics of 
861Þ. Since liver extraction is essentially complete for acrylonitrile at low levels of exposure, AUCL /CE tends to be much smaller at baseline than the corresponding value for perchloroethylene; e.g., when m X 5 0.001 mg/l, AUCL /CE is 3.8 for acrylonitrile (Fig. 5E ), compared to 53.6 for perchloroethylene (Fig. 5C) . Conversely, efficient metabolism leads to a much larger AURC/CE for acrylonitrile at baseline than for perchloroethylene; e.g., when m X 5 0.001 mg/l, AURC/CE is 1194 l/h for acrylonitrile (Fig. 5F ), compared to 66.9 l/h for perchloroethylene (Fig. 5D) . The flip-flop behavior of metabolism for acrylonitrile translates days of high exposure into days of very high liver dose (AUCL i ); as noted earlier, this results in a 7-fold increase in AUCL /CE for the high-variability scenario (when m X 5 0.1 mg/l) compared to the near-baseline value for the lowvariability scenario. Since benzene and perchloroethylene do not exhibit flip-flop kinetics, deviations from their near-baseline values of AUCL /CE are much more modest, in the range of about 2-20% (Fig. 6A) .
The picture regarding the metabolite dose was different, given maximum deviations in AURC/CE of about À30% for all three VOCs (Fig. 6B) . This is because the large baseline value of AURC/CE for acrylonitrile tended to offset the abrupt reduction in daily metabolite dose (AURC i ) occurring during the highexposure days. Since benzene and perchloroethylene do not exhibit flip-flop kinetics, their reductions in AUCL i or AURC i were more modest during the high-exposure days; but these changes were offset by their smaller baseline values of AURC/CE, yielding essentially the same percent deviations as for acrylonitrile.
Sensitivity Analysis
Results of the sensitivity analyses are summarized in Figure 7 for AUCL and in Figure 8 for AURC, based upon a 1% increase in each of the toxicokinetic parameters. The sensitivities of the two dose metrics were greatly influenced by the variability of exposure (CV X ) at a given mean exposure (m X ). That is, long-term doses were much more sensitive to changes in model parameters when CV X 5 2.18 than when CV X 5 0.23. Indeed, it was common to observe normalized sensitivity coefficients greater than 65 when CV X 5 2.18, whereas coefficients rarely exceeded 62 when CV X 5 0.23. This suggests that AUCL and AURC would vary considerably across a population exposed at a given m X when exposure was highly variable under either linear (m X 5 0.0003 mg/l) or saturated (m X 5 0.3 mg/l) kinetics. The normalized sensitivity coefficients shown in Figures 7 and 8 indicate general sensitivity to most parameters. This probably reflects the structure of the model, where all parameters, except the partition coefficients and K M , were functions of body weight and, therefore, were highly correlated. In comparing among VOCs, the most notable difference concerns sensitivity of AUCL in the high-exposure, high-variability scenario (Fig. 7D) , where deviations were negative for acrylonitrile but were positive for benzene and perchloroethylene. This probably points to the lipophobic nature of acrylonitrile (whereas the other compounds are lipophilic), because days of saturating exposure would not lead to a buildup of acrylonitrile in the fat (with subsequent release to the circulation and the liver) but rather to increased passive clearance in the exhaled air.
Regarding perturbations to the parameters that influence metabolic clearance, i.e., V max , K M , and Q L , AUCL was consistently more sensitive for benzene and acrylonitrile (highaffinity substrates) than for perchloroethylene (low-affinity substrate) (see Fig. 7 ). This suggests that factors affecting blood flow to the liver (such as exercise rate) and those influencing metabolism (such as genetic polymorphisms as well as enzyme induction and inhibition) would affect liver doses of benzene and acrylonitrile to a much greater extent than they would for the dose of perchloroethylene, particularly in situations where exposure is highly variable from day to day.
DISCUSSION
Recognition that the dose of a substance ultimately determines its toxicity has been attributed to Paracelsus in work published more than 400 years ago (Gallo, 2001) . Since then, the fields of toxicology and epidemiology have embraced the dose-response relationship as fundamental to the understanding of risks of diseases caused by chemical exposures. Unfortunately, our ability to estimate long-term doses from occupational exposures has been hampered by the variability in levels within and between persons in a given population and by the lack of historical measurements of exposure. In the face of large variability and few measurements, the ability to accurately quantify dose-response relationships is sadly limited. If exposure databases are to improve for future investigations, we must adopt sampling strategies that place a premium upon longitudinal exposure data collected according to sound statistical principles (Rappaport, 1991; Rappaport et al., 1995) . A strong motivation for such a change would be to accept by default the premise that CE is the principal determinant of the long-term internal dose received by each person in a population. However, this acceptance presumes that internal dose will be effectively proportional to m X during some period of interest, regardless of the variability in exposure levels encountered from day to day (Rappaport et al., 1995) .
The purpose of this paper has been to evaluate the premise that CE is a sufficient predictor of the internal doses of benzene, perchloroethylene, and acrylonitrile, three carcinogenic VOCs that are cleared in part by saturable metabolism over a wide range of toxicokinetic behaviors (as reflected by differing values of
. We observed in all cases that both the long-term liver dose (AUCL) and the long-term metabolite dose (AURC) were essentially linear functions of CE over about 40 simulated years of occupational exposure, even when daily-dose increments (AUCL i and AURC i ) were saturated (e.g., see Fig. 4 ). Thus, despite the enormous range of daily exposures that can be observed in the workplace, the straight-line slope representing AUCL /CE or AURC/CE after several years is essentially fixed for an individual worker at a given mean exposure (m X ).
Despite the linear relationship between AUCL or AURC and CE for an individual worker, the corresponding relationship across a population could well be nonlinear if some workers have mean air levels in the saturable range. For example, in a population of workers heavily exposed to the three VOCs investigated here, we would anticipate a concave-downwards shape in the exposure-biomarker relationship across the population for any biomarker located 'downstream' from the initial metabolic step (see Fig. 2B ). Indeed, such shapes have been reported for protein adducts and urinary metabolites of benzene (both downstream biomarkers) (Rappaport et al., 2002a,b; Waidyanatha et al., 2004) , as well as for the mortality-CE curve for lymphohematopoietic cancers among benzene-exposed workers (Hayes et al., 1996) .
Our results indicate that individual workers who experience the same CE could nonetheless have different long-term internal doses (AUCL or AURC) if their individual levels of exposure variability (values of CV X ) differed greatly. The magnitude of such deviations would depend upon the particular dose metric. Since most VOCs are metabolized to toxic products, the more important effect of exposure variability concerns its relation to the internal metabolite dose (AURC). Here, our results indicate that differences in AURC/CE (arising from different values of CV X across the population) should be small for VOCs, with maximum deviations in the range of about À30% as observed for benzene, perchloroethylene, and acrylonitrile (Fig. 6B) . We conclude that assignment of metabolite doses to VOCs, based solely on CE, should not compromise estimation of exposureresponse relationships. This conclusion is at odds with the observation of Collins et al. that the number of 'peak' exposures to benzene (greater than 100 ppm) was a better predictor of lymphohematopoietic cancers than was CE, and could point to the large uncertainties in estimation of individual CEs mentioned by the authors (Collins et al., 2003) . Another recent study found no evidence that the risk of lymphohematopoietic cancers was influenced by peak exposures (Glass et al., 2003) .
Turning now to the liver dose of a VOC per se, our results indicate that AUCL /CE can differ by several hundred percent between high-and low-variability scenarios, but only when m X and CV X are large and when
If not all three of these conditions are met, then deviations of AUCL /CE should only be a few percent (see Fig. 6A for acrylonitrile when m X 0.003 mg/ l or CV X 0.62 and for benzene and perchloroethylene at all values of m X ). Yet there could well be situations where such a nexus of three independent factors could occur. For example, if a worker was exposed to acrylonitrile in intermittent outdoor operations, giving rise to a large s 2 X (Kromhout et al., 1993) , at a mean exposure level m X 5 0.008 mg/l, we would anticipate a deviation in AUCL /CE of about 100% from that of a coworker having the same m X but low-to-moderate exposure variability (see Fig. 6A ). This mean air concentration (m X 5 0.008 mg/l) is about twice the 2004 Threshold Limit Value (2 ppm 5 4.3 mg/m 3 ) (ACGIH, 2004) and, thus, would be unacceptable by current norms. However, exposures of this magnitude could easily escape detection in the developed world, where workplace air monitoring is sporadic at best, and could be commonplace in much of the developing world. Thus, we recommend that VOCs be screened to identify chemicals with 
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RAPPAPORT, KUPPER, AND LIN Sensitivity analyses indicated that AUCL and AURC were both sensitive to small changes in the toxicokinetic parameters when CV X was large (see Figs. 7 and 8) . This suggests that populations of workers exposed to a given mean exposure could have quite different long-term liver and metabolite doses of VOCs when exposure variability is great, due to differences in toxicokinetic parameters among individuals. Since physiologically-based toxicokinetic models rarely consider exposure variability, which is often quite large for VOCs in occupational and environmental settings (Rappaport and Kupper, 2004) , our results indicate that such simulations probably underestimate the true sensitivity of model predictions to variability in model parameters across a population.
Finally, it is worth reiterating the sentiments of Clewell et al. that physiologically based toxicokinetic models offer powerful tools for investigating complex exposure-dose-response relationships in living organisms (Clewell et al., 2002) . While most such applications have focused upon interspecies extrapolations and modes of toxic action, our analyses suggest that such models also offer logical avenues for elucidating the particular effects of exposure variability upon these complex relationships.
APPENDIX
Equations Describing the Disposition of an Inhaled Volatile Organic Compound in the Body
Following Ramsey and Andersen (1984) , assuming a steady-state rate (mg h À1 ) between alveolar air and alveolar blood, the following mass-balance equation holds (for abbreviations refer to Figure 1 in the text):
Using (A1) and solving for C Art , we obtain
And, from the mass-balance equation
where the subscript g refers to the g th tissue group (richly perfused, slowly perfused, fat or liver). For g 5 1, . . . , 4, the concentration of chemical in the mixed venous blood is
For the g th nonmetabolizing tissue group (richly-perfused, slowly-perfused, or fat), the rate of change (mg h À1 ) in the amount A g (5 V g C g ) of chemical is
Finally, the metabolism of the chemical is assumed to take place exclusively in the liver according to Michaelis-Menten kinetics. The mass-balance equation determining the rate of change in chemical concentration in the liver is
